HACKENSACK, N.J., March 7 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. announced today that its year-end analyst conference call will be held March 8, 2006 at 5:30 p.m. EST. The audio Web cast can be accessed at http://www.dovpharm.com under Investor Relations and will remain archived on the Web site for 90 days.
The call-in numbers for the live teleconference are as follows: (Toll Free) 1-877-407-8031 or (International) 201-689-8031. A full replay of the conference call will be accessible through March 15, 2006. The replay can be accessed by dialing: (Toll Free) 877-660-6853 or (International) 201-612-7415 and entering Account #286 and Conference ID #195413.
About DOV
DOV is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression. Our partner Neurocrine has filed two NDAs for the use of DOV's compound indiplon for the treatment of insomnia.
DOV Pharmaceutical, Inc.CONTACT: Keri P. Mattox, Director, Investor Relations and CorporateCommunications of DOV Pharmaceutical, Inc., +1-201-968-0980
Web site: http://www.dovpharm.com/
